Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Shot in the arm for vaccines

A Flinders University research program to develop new forms of vaccine against infectious diseases has received over $3 million in funding from the United States Government's National Institutes of Health.

6 Sep 2005

GlaxoSmithKline acquires vaccine R&D and manufacturing plant in the U.S.

GlaxoSmithKline has announced that it is expanding its ability to increase vaccines supplies for Americans by acquiring a vaccine research and production facility in Marietta, Pennsylvania.

1 Sep 2005

New vaccine approved for U.S. just in time for flu season

A new flu vaccine has been approved by U.S. health officials in an attempt to bolster up supplies after last season's shortage.

31 Aug 2005

Emergent Biosolutions' typhoid vaccine achieves positive results in Phase II clinical study

Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.

30 Aug 2005

Anti-cancer antibodies produced in chickens

A team of researchers have produced the first fully functional, human sequence monoclonal antibodies (mAbs) in chickens.

29 Aug 2005

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).

24 Aug 2005

Chemists synthesize new class of carbenes - potential for pharmaceutical industry

Chemists at the University of California, Riverside have synthesized a new class of carbenes - molecules that have unusual carbon atoms - that is expected to have wide applications in the pharmaceutical industry, ultimately resulting in a reduction in the price of drugs.

22 Aug 2005

The use of salt fluoridation to prevent dental caries

A new book from the Pan American Health Organization (PAHO) shows how salt fluoridation has proven to be one of the most cost-effective public health interventions in history and shows countries how to implement programs of their own.

16 Aug 2005

Sonora Medical Unit receives patent fo ultrasound probe testing device

Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.

14 Aug 2005

Australian lambskin pressure care products granted FDA approval in the U.S.

Export opportunities into the lucrative American market have been thrown wide open for a unique South Australian range of medical lambskin products.

11 Aug 2005

MicroRNAs play an important role in regulating oogenesis

Researchers at Northwestern University and Carnegie Mellon University have found that a recently described class of molecules called microRNAs (miRNAs) play an important role in regulating oogenesis, the process by which females make eggs.

9 Aug 2005

Progress to develop vaginal microbicides

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced an agreement with the International Partnership for Microbicides (IPM) to share information and expertise in an effort to develop vaginal microbicides

4 Aug 2005

Tobacco industry is continuing its targeted marketing to teens via candy-flavored cigarettes

Advertising and promotion for these products uses hip-hop imagery, attractive women, and other imagery to appeal to youth in similar ways that Joe Camel did a decade ago.

2 Aug 2005

Drugs with similar chemical attributes as Ecstasy might offer useful alternatives to current therapies for Parkinson's disease

Amphetamines, including the drug popularly known as Ecstasy, can reverse the symptoms of Parkinson's disease in mice with an acute form of the condition, according to new research at Duke University Medical Center.

2 Aug 2005

Guidant prepared to launch heart failure devices outside the United States

Guidant Corporation has received Conformité Européenne (CE) Mark approval to launch its CONTAK RENEWAL 4 cardiac resynchronization therapy defibrillators for use outside the United States.

26 Jul 2005

Investigational vaccine against Clostridium difficile

Acambis has announced that earlier this month it started a Phase I clinical trial of its investigational vaccine against Clostridium difficile (C. difficile).

26 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

Sanofi pasteur gear up for influenza pandemic with new plant

Work has officially begun on the construction of a new sanofi pasteur manufacturing facility that will expand the ability of the United States to produce influenza vaccine for both routine influenza immunization and in case of a global influenza pandemic.

21 Jul 2005

University of Florida researcher finds way to explore role of microRNAs in specific tissue

University of Florida researchers have learned how to selectively shut down a flyweight-sized genetic molecule that packs a heavyweight punch, a discovery that may help doctors better understand cancer, birth defects and other health problems.

20 Jul 2005

Results demonstrate the safety and tolerability of ABthrax treatment for Anthrax infection

Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin

19 Jul 2005